AHRQ Safety Program for Improving Antibiotic Use

There are several options for empiric therapy but for most patients, ampicillin-sulbactam and azithromycin or ceftriaxone and azithromycin are reasonable choices. Both of these agents provide similar coverage for common bacteria causes of CAP but ceftriaxone has a stronger association with the development of ................
................